127 related articles for article (PubMed ID: 21751775)
1. Structure--activity relationship between the in vivo skin sensitizing potency of analogues of phenyl glycidyl ether and the induction of Nrf2-dependent luciferase activity in the KeratinoSens in vitro assay.
Delaine T; Niklasson IB; Emter R; Luthman K; Karlberg AT; Natsch A
Chem Res Toxicol; 2011 Aug; 24(8):1312-8. PubMed ID: 21751775
[TBL] [Abstract][Full Text] [Related]
2. Impact of a heteroatom in a structure-activity relationship study on analogues of phenyl glycidyl ether (PGE) from epoxy resin systems.
Niklasson IB; Delaine T; Luthman K; Karlberg AT
Chem Res Toxicol; 2011 Apr; 24(4):542-8. PubMed ID: 21370839
[TBL] [Abstract][Full Text] [Related]
3. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro.
Emter R; Ellis G; Natsch A
Toxicol Appl Pharmacol; 2010 Jun; 245(3):281-90. PubMed ID: 20307559
[TBL] [Abstract][Full Text] [Related]
4. The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: results of a ring-study in five laboratories.
Andreas N; Caroline B; Leslie F; Frank G; Kimberly N; Allison H; Heather I; Robert L; Stefan O; Hendrik R; Andreas S; Roger E
Toxicol In Vitro; 2011 Apr; 25(3):733-44. PubMed ID: 21195160
[TBL] [Abstract][Full Text] [Related]
5. Contact allergenic potency: correlation of human and local lymph node assay data.
Gerberick GF; Robinson MK; Ryan CA; Dearman RJ; Kimber I; Basketter DA; Wright Z; Marks JG
Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
[TBL] [Abstract][Full Text] [Related]
6. Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment.
Natsch A; Emter R; Gfeller H; Haupt T; Ellis G
Toxicol Sci; 2015 Feb; 143(2):319-32. PubMed ID: 25338925
[TBL] [Abstract][Full Text] [Related]
7. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
[TBL] [Abstract][Full Text] [Related]
8. Relating skin sensitizing potency to chemical reactivity: reactive Michael acceptors inhibit NF-κB signaling and are less sensitizing than S(N)Ar- and S(N)2- reactive chemicals.
Natsch A; Haupt T; Laue H
Chem Res Toxicol; 2011 Nov; 24(11):2018-27. PubMed ID: 22023385
[TBL] [Abstract][Full Text] [Related]
9. Local lymph node assay (LLNA) for detection of sensitization capacity of chemicals.
Gerberick GF; Ryan CA; Dearman RJ; Kimber I
Methods; 2007 Jan; 41(1):54-60. PubMed ID: 16938465
[TBL] [Abstract][Full Text] [Related]
10. Filling the concept with data: integrating data from different in vitro and in silico assays on skin sensitizers to explore the battery approach for animal-free skin sensitization testing.
Natsch A; Emter R; Ellis G
Toxicol Sci; 2009 Jan; 107(1):106-21. PubMed ID: 18832184
[TBL] [Abstract][Full Text] [Related]
11. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
Schneider K; Akkan Z
Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
[TBL] [Abstract][Full Text] [Related]
12. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
[TBL] [Abstract][Full Text] [Related]
13. Reduced sensitizing capacity of epoxy resin systems: a structure-activity relationship study.
Niklasson IB; Broo K; Jonsson C; Luthman K; Karlberg AT
Chem Res Toxicol; 2009 Nov; 22(11):1787-94. PubMed ID: 19725531
[TBL] [Abstract][Full Text] [Related]
14. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
[TBL] [Abstract][Full Text] [Related]
15. Use of an ex vivo local lymph node assay to assess contact hypersensitivity potential.
Piccotti JR; Kawabata TT
J Immunotoxicol; 2008 Jul; 5(3):271-7. PubMed ID: 18830887
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic applicability domain classification of a local lymph node assay dataset for skin sensitization.
Roberts DW; Patlewicz G; Kern PS; Gerberick F; Kimber I; Dearman RJ; Ryan CA; Basketter DA; Aptula AO
Chem Res Toxicol; 2007 Jul; 20(7):1019-30. PubMed ID: 17555332
[TBL] [Abstract][Full Text] [Related]
17. Assessment of potency of allergenic activity of low molecular weight compounds based on IL-1alpha and IL-18 production by a murine and human keratinocyte cell line.
Van Och FM; Van Loveren H; Van Wolfswinkel JC; Machielsen AJ; Vandebriel RJ
Toxicology; 2005 Jun; 210(2-3):95-109. PubMed ID: 15840424
[TBL] [Abstract][Full Text] [Related]
18. The local lymph node assay and the assessment of relative potency: status of validation.
Basketter DA; Gerberick F; Kimber I
Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
[TBL] [Abstract][Full Text] [Related]
19. Assessment of chemical skin-sensitizing potency by an in vitro assay based on human dendritic cells.
Lambrechts N; Vanheel H; Nelissen I; Witters H; Van Den Heuvel R; Van Tendeloo V; Schoeters G; Hooyberghs J
Toxicol Sci; 2010 Jul; 116(1):122-9. PubMed ID: 20375081
[TBL] [Abstract][Full Text] [Related]
20. Predictive identification of human skin sensitization thresholds.
Basketter DA; Clapp C; Jefferies D; Safford B; Ryan CA; Gerberick F; Dearman RJ; Kimber I
Contact Dermatitis; 2005 Nov; 53(5):260-7. PubMed ID: 16283904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
